These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
859 related articles for article (PubMed ID: 19302071)
1. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer. Attili SK; Lesar A; McNeill A; Camacho-Lopez M; Moseley H; Ibbotson S; Samuel ID; Ferguson J Br J Dermatol; 2009 Jul; 161(1):170-3. PubMed ID: 19302071 [TBL] [Abstract][Full Text] [Related]
2. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy. Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460 [TBL] [Abstract][Full Text] [Related]
3. Ambulatory photodynamic therapy using low irradiance inorganic light-emitting diodes for the treatment of non-melanoma skin cancer: an open study. Ibbotson SH; Ferguson J Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):235-9. PubMed ID: 22971187 [TBL] [Abstract][Full Text] [Related]
4. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma. Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606 [TBL] [Abstract][Full Text] [Related]
6. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer. de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503 [TBL] [Abstract][Full Text] [Related]
7. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light]. Harth Y; Hirshovitz B Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421 [TBL] [Abstract][Full Text] [Related]
8. Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy. Moseley H; Allen JW; Ibbotson S; Lesar A; McNeill A; Camacho-Lopez MA; Samuel ID; Sibbett W; Ferguson J Br J Dermatol; 2006 Apr; 154(4):747-50. PubMed ID: 16536822 [TBL] [Abstract][Full Text] [Related]
9. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Itkin A; Gilchrest BA Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of nonmelanoma skin cancer with topical hypericum perforatum extract--a pilot study. Kacerovská D; Pizinger K; Majer F; Smíd F Photochem Photobiol; 2008; 84(3):779-85. PubMed ID: 18179625 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease. Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828 [TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Morton CA; Whitehurst C; McColl JH; Moore JV; MacKie RM Arch Dermatol; 2001 Mar; 137(3):319-24. PubMed ID: 11255332 [TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Ericson MB; Sandberg C; Stenquist B; Gudmundson F; Karlsson M; Ros AM; Rosén A; Larkö O; Wennberg AM; Rosdahl I Br J Dermatol; 2004 Dec; 151(6):1204-12. PubMed ID: 15606516 [TBL] [Abstract][Full Text] [Related]
14. Photofrin-mediated photodynamic therapy for treatment of aggressive head and neck nonmelanomatous skin tumors in elderly patients. Gayl Schweitzer V Laryngoscope; 2001 Jun; 111(6):1091-8. PubMed ID: 11404627 [TBL] [Abstract][Full Text] [Related]
16. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy. Stables GI; Stringer MR; Robinson DJ; Ash DV Br J Dermatol; 1997 Jun; 136(6):957-60. PubMed ID: 9217836 [TBL] [Abstract][Full Text] [Related]
17. A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer. Zeitouni NC; Paquette AD; Housel JP; Shi Y; Wilding GE; Foster TH; Henderson BW Lasers Surg Med; 2013 Feb; 45(2):89-94. PubMed ID: 23390058 [TBL] [Abstract][Full Text] [Related]
18. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma. Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077 [TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical outcomes of oral erythroleukoplakia treated with photodynamic therapy using either light-emitting diode or laser light. Yu CH; Lin HP; Chen HM; Yang H; Wang YP; Chiang CP Lasers Surg Med; 2009 Nov; 41(9):628-33. PubMed ID: 19816916 [TBL] [Abstract][Full Text] [Related]
20. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments? Morton CA J Dermatolog Treat; 2002; 13 Suppl 1():S25-9. PubMed ID: 12060514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]